ArticleCancer chemotherapy and pharmacology2022

Adaptive dosing of sunitinib in a metastatic renal cell carcinoma patient: when in silico modeling helps to go quicker to the point.

Florent Ferrer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.